AcelRx Pharmaceuticals Inc (ACRX) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. ACRX received an overall rating of 47, which means that it scores higher than 47 percent of all stocks. AcelRx Pharmaceuticals Inc also achieved a score of 79 in the Drug Manufacturers - Specialty & Generic industry, putting it above 79 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 131 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 47 would rank higher than 47 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With AcelRx Pharmaceuticals Inc Stock Today?
AcelRx Pharmaceuticals Inc (ACRX) stock is unchanged 0.44% while the S&P 500 has risen 0.58% as of 10:37 AM on Wednesday, Jul 8. ACRX is flat $0.00 from the previous closing price of $1.13 on volume of 191,335 shares. Over the past year the S&P 500 is higher by 6.18% while ACRX is down -57.93%. ACRX lost -$0.70 per share the over the last 12 months.
To see InvestorsObserver's Sentiment Score for AcelRx Pharmaceuticals Inc click here.
